Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs. Ketamine for ECT in Depression and Bipolar Disorder
2012-001341-41Phase 4Completed
- Sponsor
- Universitätsklinik für Psychiatrie und Psychotherapie I
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine, propofol in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Universitätsklinik für Psychiatrie und Psychotherapie I. Started Jun 2012; status: completed.
02
Drugs
ketaminepropofol
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on 2012-001341-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001341-41.